Vaccines
From the Journals
FDA approves first RSV vaccine for pregnancy
The vaccine can be given between weeks 32 and 36 of pregnancy and is designed to protect infants from the virus from birth to 6 months of age.
Latest News
CDC tracking new COVID strain
“More data are needed to understand this COVID-19 variant and the extent of its spread, but the number of mutations warrants attention.”
From the Journals
On the trail of a new vaccine for Lyme disease
“This is a key piece of data that opens the door to one day having an innovative vaccination strategy aimed at perturbing the microbiota of the...
Latest News
Telehealth visit helps reconnect adolescents lost to follow-up
A small pilot study finds positive results in a hybrid model: The first visit is telehealth with in-person follow-up as needed.
Latest News
New COVID shots will be available in September
“We are likely to see this as a recommendation as an annual COVID shot, just as we have an annual flu shot.”
Latest News
Long COVID–induced activity limitations persist
The prevalence of long COVID in the United States has remained stable, as has the proportion of patients reporting significantly reduced function...
Conference Coverage
Offering HPV vaccine at age 9 linked to greater series completion
Despite recommendations to bundle HPV vaccine administration with that of Tdap and meningococcal vaccines, offering it sooner increases the...
Latest News
Family physicians get lowest net return for HPV vaccine
Family physicians’ net return from cost reimbursements was $0.34 per dose. The net for pediatricians was $5.08 per dose.
Feature
Innovations in pediatric chronic pain management
Virtual reality, bundled visits, and massage therapists are among innovative options at centers for treating kids’ chronic pain.
Practice Alert
Polio in the US? Yes, and it prompted ACIP to update its recs
Last summer, a case of paralytic polio was confirmed in New York—with subsequent evidence of the virus in wastewater. Now, the Advisory Committee...
Latest News
Partial immunization leaves children and communities at risk, study finds
The strongest association with not completing the vaccine series was moving across state lines and not having insurance.